Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Kidney & Renal Pelvis (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count ascending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 4.9 (4.8, 4.9) N/A 19,323 28.7
California 3 4.5 (4.5, 4.6) 37 (29, 42) 2,043 30.8
Texas 3 5.8 (5.7, 6.0) 6 (2, 10) 1,748 28.6
Florida 6 4.3 (4.2, 4.4) 43 (38, 45) 1,318 28.1
New York 3 4.6 (4.5, 4.7) 33 (27, 42) 1,151 28.2
Illinois 3 5.4 (5.2, 5.6) 12 (7, 23) 842 30.3
Ohio 6 5.4 (5.2, 5.6) 13 (7, 23) 812 30.7
Pennsylvania 6 4.6 (4.4, 4.7) 35 (27, 43) 794 28.3
North Carolina 6 5.0 (4.8, 5.1) 26 (19, 31) 639 26.8
Georgia 3 5.2 (5.0, 5.4) 22 (11, 27) 629 29.3
Michigan 6 4.7 (4.5, 4.9) 30 (24, 41) 613 29.4
New Jersey 3 4.6 (4.4, 4.8) 34 (26, 43) 530 29.4
Missouri 6 5.7 (5.4, 5.9) 7 (3, 20) 440 29.2
Tennessee 6 5.1 (4.8, 5.3) 25 (14, 30) 434 25.8
Washington 5 4.7 (4.5, 4.9) 29 (23, 41) 428 30.8
Wisconsin 6 5.5 (5.3, 5.7) 11 (5, 24) 422 29.5
Virginia 6 4.0 (3.8, 4.2) 46 (43, 49) 416 25.4
Arizona 6 4.5 (4.3, 4.7) 38 (26, 45) 407 28.2
Massachusetts 3 4.5 (4.3, 4.7) 39 (26, 45) 398 30.4
Minnesota 6 5.5 (5.3, 5.8) 9 (5, 23) 383 30.9
Louisiana 3 6.4 (6.1, 6.7) 1 (1, 5) 360 28.1
Kentucky 3 5.9 (5.6, 6.2) 5 (1, 14) 334 28.3
South Carolina 6 4.7 (4.4, 4.9) 31 (23, 43) 309 27.1
Maryland 6 3.9 (3.7, 4.1) 48 (44, 50) 292 25.5
Oklahoma 6 6.0 (5.7, 6.3) 4 (1, 12) 283 29.1
Alabama 6 4.4 (4.2, 4.6) 42 (28, 46) 279 24.3
Colorado 6 3.9 (3.7, 4.2) 47 (43, 50) 256 27.1
Iowa 3 6.1 (5.8, 6.5) 2 (1, 11) 253 31.2
Oregon 6 4.4 (4.2, 4.7) 41 (27, 46) 243 29.2
Connecticut 3 4.6 (4.3, 4.8) 36 (24, 45) 212 29.4
Arkansas 6 5.3 (4.9, 5.6) 21 (7, 29) 197 25.5
Mississippi 6 5.3 (4.9, 5.6) 20 (6, 29) 193 24.7
Kansas 6 5.4 (5.0, 5.7) 16 (4, 28) 185 27.4
West Virginia 6 6.1 (5.6, 6.5) 3 (1, 15) 154 29.5
New Mexico 3 5.6 (5.2, 6.0) 8 (2, 25) 149 35.2
Nevada 6 3.6 (3.4, 3.9) 49 (45, 50) 134 26.4
Utah 3 4.4 (4.1, 4.8) 40 (24, 47) 130 28.6
Nebraska 6 5.4 (4.9, 5.8) 15 (4, 29) 124 29.5
Maine 6 5.3 (4.9, 5.8) 17 (3, 32) 108 31.6
Idaho 3 4.8 (4.4, 5.2) 28 (14, 45) 103 26.3
New Hampshire 6 4.6 (4.2, 5.1) 32 (17, 47) 89 28.0
Puerto Rico 6 2.1 (1.9, 2.3) N/A 88 24.0
Hawaii 3 4.3 (3.9, 4.8) 44 (25, 49) 83 32.9
Rhode Island 6 5.5 (5.0, 6.1) 10 (1, 31) 77 33.4
Montana 6 4.9 (4.3, 5.4) 27 (8, 45) 70 28.6
South Dakota 6 5.3 (4.7, 6.0) 19 (2, 42) 58 30.0
Delaware 6 4.1 (3.6, 4.7) 45 (25, 50) 54 24.2
North Dakota 6 5.2 (4.5, 5.9) 23 (2, 44) 48 27.8
Vermont 6 5.2 (4.5, 5.9) 24 (2, 45) 47 34.3
Alaska 6 5.4 (4.6, 6.2) 14 (1, 44) 42 29.0
Wyoming 6 5.3 (4.6, 6.1) 18 (1, 44) 39 35.1
District of Columbia 6 3.2 (2.6, 3.8) 50 (45, 50) 22 25.8
Indiana 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 05/16/2025 2:46 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top